News
-
-
-
COMMUNIQUÉ DE PRESSE
Lonza Upgrades Organic Growth Model and Mid-term Financial Ambitions at Capital Markets Day; Q3 2026 In Line with Expectations
Lonza upgrades Organic Growth Model and Mid-term Financial Ambitions at Capital Markets Day; Q3 2026 In Line with Expectations. Lonza reports progress on long-term growth strategy and operational performance -
-
-
COMMUNIQUÉ DE PRESSE
Lonza Expands Dual-Payload ADC Technology Offering Through Exclusive Access to Qurient’s CDK7 Inhibitors
Lonza announces exclusive access to Qurient's CDK7 inhibitors for dual-payload ADC technology, enhancing its position in the growing market. The agreement strengthens Lonza's ADC toolbox with new SYN-duo® CC format -
-
-
-
